Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study
Gadgeel SM et al. Lung Cancer 2019; 128: 105-112. doi:10.1016/j.lungcan.2018.12.017
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.